RegenMed

03/09/2022

Clinical realities may require quick and efficient protocol updates, even long after patients have been enrolled and reporting their outcomes. Our latest technology update allows users to seamlessly make changes to their protocols on the go, while preserving earlier versions for data integrity and auditing purposes.

03/09/2022

Conditional question logic for patient surveys has arrived! Circle Founders can now reduce large, multi-variable patient surveys into streamlined, personalized user experiences. This allows for more responsive, deeper questioning into more relevant areas of interest. Learn more here: https://lnkd.in/dtqwAY48

02/03/2022

The is issuing a series of draft guidances for industry on aspects of and in regulatory decision-making. The agency issued four of these guidances in late 2021 and plans to issue more guidance this year on designing studies that use RWD, specifically externally controlled trials and randomized controlled trials conducted in clinical practice settings. Read the full story here:

What this series of guidances may mean for industry, healthcare providers, and patients

02/01/2022

Looking for new ways to collaborate with your clinical peers? RegenMed’s Circles engage practitioners from around the world in aggregating and benchmarking their novel real-world evidence to advance medicine. Learn more today: https://www.rgnmed.com/circles/practitioners

12/14/2021

Clinical practices offer a trove of valuable real-world data. RegenMed's evidence-based network connects practitioners from around the world in generating, aggregating, and monetizing such data from their clinical practices. Learn more about starting an evidence-based collaborative today:

Clinical Circles are designed to identify and productively connect healthcare professionals with similar evidence-based interests and pursuits. They combine an approach, services, and technology which eliminates traditionally costly logistics, and allows Circle Members to dedicate their limited time...

12/14/2021

There are more ways to connect with patients thanks to our most recent technology release: Kronos. Patients can now receive their follow-up reminders through SMS text messages, which powered through AWS, are available through local mobile carriers across more than 200 countries. Read about Kronos: https://lnkd.in/eu43s6pG

11/12/2021

Circles are collaborative solutions which connect a medical distributor's clinical customers in the generation and dissemination of around product use and results. These peer-to-peer, evidence-based discussions support a diverse number of commercial, scientific and regulatory goals. Learn more at: www.rgnmed.com/circles

11/03/2021

Plasmaconcept AG has chosen Circles to conduct a multi-center, post-market surveillance study on its IM.P.A.C.T. platform for autologous . The Circle will aggregate longitudinal outcomes data from real-world patients suffering from and of various joints. Key clinical criteria, such as the specific dosages of erythrocytes, leukocytes and platelets chosen for each indication, will support meaningful correlations to advance working knowledge on autologous cell therapy dosages. Read the full story here: https://www.rgnmed.com/post/plasmaconcept-ag-prepares-circles-for-2022-post-market-surveillance-strategy

11/01/2021

Circles are collaborative solutions which help your clinical customers generate, benchmark and share on use of your products. These discussions, and their evidence-based results, drive commercial, clinical and scientific value which supports a number of product manufacturer and distributor goals. https://www.rgnmed.com/circles/distributors

10/28/2021

Cutting-edge manufacturers and distributors are increasingly turning to to surveil their in-market products, including for adverse event reporting, outcomes monitoring, and various other regulatory, marketing and research purposes. Read more on the rising role of in healthcare, and its growing applicability to post-market product strategies. https://bit.ly/2XXmw4K

10/21/2021

Convert your practice into a profit-center with RegenMed’s Circles. Circle members collect longitudinal from their routine clinical care, compare results and insights among likeminded professionals around the world, and convert their discoveries into publications, patient marketing materials, sponsored studies, and much more. Learn more today - https://www.rgnmed.com/

10/20/2021

On October 28th, the latest inCytes™ release will provide Circle members with a more robust dashboard for monitoring, following up, and analyzing their patients’ long-term outcomes. Fostering patient compliance, satisfaction, and engagement remain core principles for any RegenMed Circle.